Their own payment-practices filing · gov.uk
How long does Genzyme Therapeutics Limited take to pay its suppliers?
Self-reported figure from their statutory filing. How this is compiled.
On the public register · Companies House
Company record
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 5 Nov 2001
- Registered office
- 410 THAMES VALLEY PARK DRIVE, READING, RG6 1PT
Terms vs reality
Stated terms: 0–60 days. Reported average: 98.
At a glance
The key figures
Vs peers · latest reported averages
The pattern
Getting slower
Average days to pay across their last 6 statutory reports.
Where their supplier invoices land · latest period
The read · computed from their figures
Genzyme Therapeutics Limited has filed 6 statutory payment periods (earliest H1 2018). Their latest report puts the average at 98 days against stated terms of 0–60 days.
The direction is slower: from 51 to 98 days over the window — about 47 days slower.
In the latest period 82% of invoices were paid outside their agreed terms, and 82% landed 61+ days out.
What they tell their suppliers
In their own words · from the filing
Standard payment terms
Standard payment terms are 60 days from the date of receipt of a valid and correct invoice
Dispute resolution
In the first instance disputes will be received by our Invoice processing contact centre at the defined email address or telephone number printed on every Purchase Order. Queries will then be forwarded to the requester of the service/goods for information and evaluation. Failure to meet resolution will be escalated to the Head of Purchase to Pay and include the specific Category Buyer for the service/goods that is responsible for the vendor relationship.
Other information
Intercompany invoices and performance have been included in reported statistics. These in general are wholly owned by group companies and do distort performance (detrimentally) as more emphasis and monitoring is put on payment to third parties. The third parties payments have decreased to a low volume, due to the legal entity being merged and closed. This is reflected in the significant reported payment performance change. Payment late overall 82%- Third party is 23% but Interco is 98%.
Every statutory report on record
Most recent first.
| Period | Avg days | Outside terms | 61+ days | Filed |
|---|---|---|---|---|
| H2 2020 | 98 | 82% | 82% | 18 Jan 2021 |
| H1 2020 | 39 | 38% | 15% | 15 Jul 2020 |
| H2 2019 | 37 | 12% | 12% | 16 Jan 2020 |
| H1 2019 | 44 | 12% | 8% | 25 Jul 2019 |
| H2 2018 | 47 | 11% | 6% | 24 Jan 2019 |
| H1 2018 | 51 | 28% | 17% | 18 Jul 2018 |
Working-capital effect
What a 98-day cycle ties up
Illustrative. On a hypothetical £12k/month account, at a 98-day vs a 0-day payment cycle.
Late Payment Act. The Late Payment of Commercial Debts Act lets a supplier charge statutory interest and fixed compensation on invoices paid past agreed terms. Work out what a late invoice is worth → Whether it applies depends on your contract — check with an adviser.
Quick answers
Are they getting slower or faster?
What's their typical pay point?
Can I see what this means for my invoices?
Stay ahead
Watch Genzyme Therapeutics Limited (free)
Their next payment report is due ≈ 28 Jul 2021. We watch their public record and email you when something changes — a new payment report, late filings, insolvency markers, new charges.
You’ll get a confirmation email first. Unsubscribe any time. How we handle your address.
More large companies in professional & technical services
Genus Breeding Limited · GFK U.k. Limited · Genome Research Limited · GKN Automotive Limited · Genesis Oil & Gas Consultants Limited · Glaxosmithkline Research & Development Limited
How UK payment reporting works
What is a Payment Practices Report?
What does "paid outside agreed terms" mean?
How often is this data updated?
Is this official government data?
How this is compiled. Built from official records only: Companies House and the gov.uk payment-practices service. The payment figures are self-reported — companies over the size threshold must file them by law and the board signs them off. No credit-agency data. The numbers are theirs; the plain-English read is ours. This is information compiled from public records under the Open Government Licence v3.0 — not a credit rating and not advice.
The 31-day comparison figure is the median across 6,185 companies with a current statutory report — every sector pooled, not an average of sector medians (how the figure is built).
Report PL-04316333 · latest period to 30 Dec 2020
Built by YORXEN LTD · registered in England & Wales · CRN 17303256 · privacy · terms.